English TENDERS PHARMACOVIGILANCE Advanced Search ABOUT COMPANY PRODUCTS FOR SPECIALISTS CONTACTS Ministry of Health of Russia Ministry of Industry and Trade of Russia Federal Service for Supervision of Consumer Rights Protection Federal Service for Surveillance in Healthcare State Corporation Rostec NEWS 01.10.2014 Russia has created a strategic reserve of antibacterial drugs in case of emergency situations (ES), like the September flood in the Krasnodar Territory, Rostov Region and the Crimean Federal District September 26, 2014 A well-deserved victory in the Spartakiad "Health 2013-2014" was won by a team of athletes from the NGO "Immunopreparat", a branch of the NGO "Microgen" in Ufa 09/25/2014 In the Ufa branch of NPO Microgen, a pilot series of a new split-vaccine against influenza using an experimental erythrocyte-free technology has been produced 24.09.2014 The new production of NPO Virion was highly appreciated by specialists in the framework of the international forum "Pharmaceuticals and Medical Devices" held in Tomsk © FSUE NPO Microgen 2014 Feedback Site creation - Trilan

English TENDERS PHARMACOVIGILANCE Advanced Search ABOUT COMPANY PRODUCTS FOR SPECIALISTS CONTACTS ABOUT NPO MICROGEN Home > About NPO Microgen Research and Production Association "Microgen" was formed in 2003 as a result of the merger of unitary state enterprises producing immunobiological drugs. Preservation and enhancement of the scientific and production potential of the Russian Federation in the field of creating effective and safe immunobiological drugs to improve the quality of life of citizens and improve the health of the nation is the main priority of the NPO Microgen. NPO Microgen is one of the three leaders of Russian pharmaceutical companies and is the largest national manufacturer of immunobiological preparations: vaccines, sera, specific immunoglobulins, nutrient media, allergens, probiotics. A unique direction of scientific and industrial activity of NPO Microgen is the production of bacteriophages - safe antibacterial drugs, an effective alternative to antibiotics. NPO Microgen produces more than 60 drugs included in the list of vital and important drugs and more than 120 names of immunobiological drugs, including 13 vaccines of the National Calendar of Preventive Vaccinations and 10 vaccines against socially significant infectious diseases. The history of NPO Microgen branches, such as Perm NPO Biomed (Perm), Immunopreparat (Ufa) and NPO Virion (Tomsk), has more than 100 years of scientific and industrial activity and directly related to the origins of Russian immunological science. The main production sites of NPO Microgen are located in Stavropol, Irkutsk, Nizhny Novgorod, Makhachkala, Moscow, Omsk, Tomsk, Perm and Ufa. The staff is more than 6,000 people, including more than 130 candidates of sciences, more than 30 doctors of sciences and professors. NPO Microgen presentation (.pdf) * according to data for 2012 DSM group, Remedium, Pharmvestnik. © FSUE NPO Microgen 2014 Feedback